Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
A recently developed technology called CRISPR/Cas9 allows scientists to quickly and precisely edit DNA in living cells and is about to revolutionize molecular biology and genetics. The success of CRISPR/Cas9 is based on its ease of use, effectiveness and cost efficiency. Our aim is to explore a variant of this technology, CRISPR/Cpf1, for its application in genomic engineering and potential benefits. Specifically, we want to systematically address whether CRISPR/Cpf1 can be used to manipulate any gene of interest in the genome, and whether it matches or exceeds the functionality of CRISPR/Cas9. In a second step, we aim to use this technology to improve existing cell-based production systems for biologic drugs such as therapeutic antibodies used in cancer treatment.
Biochemistry / Molecular biology
Information and communications technologies
University of Toronto
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.